INTELLIPHARM

Intellipharm, LLC was founded by Kevin C. Johnson, an internationally renowned pharmaceutical scientist known for his research on modeling drug dissolution, absorption, and content uniformity. He is recognized for his development of the maximum absorbable dose calculation. After graduating from Kalamazoo College with a BA in chemistry, Kevin earned a Ph.D. in Pharmaceutics from The University of Michigan under the direction of Professor Gordon L. Amidon. Kevin joined Pfizer in 1986 and was awarded the Pfizer Central Research Achievement Award in 1998 "for improving the survival prospects of a number of emerging new drug candidates through personal initiative and scientific insight in defining the physical properties which increase oral absorption of the drug into the body." He is a co-inventor on a ziprasidone patent for identifying a more soluble salt form of the drug... Let Intellipharm make you more efficient in selecting and developing drug products, saving you time and money.

Also known as: Intellipharm, LLC

Primary location: Cambridge United States